![An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530) | Cell Death & Disease An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530) | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fcddis.2013.442/MediaObjects/41419_2013_Article_BFcddis2013442_Fig1_HTML.jpg)
An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530) | Cell Death & Disease
![Cells | Free Full-Text | E-Cadherin in Pancreatic Ductal Adenocarcinoma: A Multifaceted Actor during EMT Cells | Free Full-Text | E-Cadherin in Pancreatic Ductal Adenocarcinoma: A Multifaceted Actor during EMT](https://www.mdpi.com/cells/cells-09-01040/article_deploy/html/images/cells-09-01040-g001-550.jpg)
Cells | Free Full-Text | E-Cadherin in Pancreatic Ductal Adenocarcinoma: A Multifaceted Actor during EMT
![Epithelial-to-mesenchymal transition in gallbladder cancer: from clinical evidence to cellular regulatory networks | Cell Death Discovery Epithelial-to-mesenchymal transition in gallbladder cancer: from clinical evidence to cellular regulatory networks | Cell Death Discovery](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fcddiscovery.2017.69/MediaObjects/41420_2017_Article_BFcddiscovery201769_Fig1_HTML.jpg)